Inventor
ZERANGUE NOA
US25 patents
⚠️ This page may combine multiple inventors who share the name “ZERANGUE NOA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENOPORT INC
18 patentsUS7351740B2Apr 1, 2008
Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
XENOPORT INC43 citations96
US7592369B2Sep 22, 2009
Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
XENOPORT INC10 citations84
US7462459B2Dec 9, 2008
LAT1 transporters expressed in blood brain barrier cells
XENOPORT INC14 citations84
US7994218B2Aug 9, 2011
Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
XENOPORT INC14 citations83
US7507546B2Mar 24, 2009
Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
XENOPORT INC11 citations82
US7777070B2Aug 17, 2010
Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
XENOPORT INC1 citations63
US7452680B2Nov 18, 2008
MCT1 transporters expressed in blood brain barrier cells
XENOPORT INC5 citations62
US8372881B2Feb 12, 2013
Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
XENOPORT INC0 citations52
US7683043B2Mar 23, 2010
Creatine phosphate analog prodrugs, compositions and uses thereof
XENOPORT INC0 citations52
US9452972B2Sep 27, 2016
Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
XENOPORT INC0 citations51
US7645797B2Jan 12, 2010
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
XENOPORT INC1 citations51
US7919454B2Apr 5, 2011
Methods of treating using conjugates transported by a PEPT2 transporter
XENOPORT INC0 citations50
US7704696B2Apr 27, 2010
Screening of compounds for OCTN2 transporter activity
XENOPORT INC0 citations41
US7704695B2Apr 27, 2010
Screening of compounds for BGT1 transporter activity
XENOPORT INC0 citations41
US7700300B2Apr 20, 2010
Screening of compounds for GAT2 transporter activity
XENOPORT INC0 citations41
US7691584B2Apr 6, 2010
Screening of compounds for OCT3 transporter activity
XENOPORT INC0 citations41
US7670782B2Mar 2, 2010
Screening of compounds for CAT1 transporter activity
XENOPORT INC0 citations41
US7625718B2Dec 1, 2009
SVCT2 transporters expressed in blood brain barrier cells
XENOPORT INC0 citations41
GANGAKHEDKAR ARCHANA
3 patentsUS8778991B2Jul 15, 2014
Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
GANGAKHEDKAR ARCHANA66 citations96
US8148414B2Apr 3, 2012
Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
GANGAKHEDKAR ARCHANA65 citations96
US8785443B2Jul 22, 2014
Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
GANGAKHEDKAR ARCHANA16 citations91